Trials / Unknown
UnknownNCT02001285
Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation
Comparison of the Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Ordinary Tracheal and Double-lumen Endobronchial Intubation During Propofol-remifentanil Total Intravenous Anesthesia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Jeju National University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is the comparison of the effect-site concentration of remifentanil for blunting hemodynamic responses to ordinary tracheal and double-lumen endobronchial intubation during propofol-remifentanil total intravenous anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil | During intubation, remifentanil will be infused to prevent change arterial blood pressure and heart rate. |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2013-12-04
- Last updated
- 2013-12-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02001285. Inclusion in this directory is not an endorsement.